USPTO serial 79449250
AVAXMED
Reviewed by CopyMark Law Group
Status 640Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- BODRI, KRISTIN MARIE
- Law office
- TMEG LAW OFFICE 105
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with AVAXMED?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, biopharmaceutical and veterinary preparations and substances for the treatment of and protection against disease; pharmaceutical, biopharmaceutical and veterinary preparations and substances for the treatment of or protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substances; vaccines; prophylactic vaccines; therapeutic vaccines; vaccine preparations; biological preparations for medical use; biological, chemical and biochemical reagents for medical use; contraceptive preparations and substances. | ACTIVE | — |
| 010 | Surgical, medical, dental and veterinary apparatus and instruments; drug delivery devices; actuator devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations parenterally; actuator devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations into subcutaneous tissue; actuator devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intradermal tissue; actuator devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intramuscular tissue; drug delivery devices, namely, drug cassettes, sold empty; injectors for medical purposes sold empty; needle-free injectors for medical purposes sold empty; injectors with needles for medical purposes sold empty; drug delivery devices, including medical injectors, needle-free injectors and parts and fittings therefore; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations parenterally; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations into subcutaneous tissue; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intradermal tissue; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intramuscular tissue; drug cassettes for use in drug delivery devices to contain pharmaceutical and biopharmaceutical preparations and substances for therapeutic, prophylactic and diagnostic use; parts and fittings for all the aforesaid goods. | ACTIVE | — |
| 042 | Medical and veterinary research and development services; medical and veterinary device development services; pharmaceutical and biopharmaceutical development services; pharmaceutical and biopharmaceutical delivery system development services; pharmaceutical and biopharmaceutical product development, namely research and formulation of pharmaceuticals and biopharmaceuticals; research into vaccines; medical and veterinary device and product testing services; provision of information relating to the aforesaid services; consultancy in relation to the aforesaid services. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 27, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 26, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 17, 2026 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Jun 12, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 11, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 6, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 5, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 5, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 7, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |